Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by jwalliscaon May 26, 2020 10:48am

104 Views

Post# 31072883

Snapshot of Level II & BIG WALL

News, news, hurry up please!

Level II Snapshot - BIG WALL... 19½ to 21½ cents

Number of Shares		Bid Price
63,500 shares	63,500	0.190
125,000 shares	125,000	0.185
121,000 shares	121,000	0.180
25,000 shares	25,000	0.175
5,000 shares	5,000	0.170
61,000 shares	61,000	0.165
83,000 shares	83,000	0.160
53,500 shares	53,500	0.155
151,500 shares	151,500	0.150
40,500 shares	40,500	0.145

Level two quotes - Ask
Ask Price	Number of Shares
0.195	281,500	281,500 shares
0.200	466,000	466,000 shares
0.210	92,000	92,000 shares
0.215	114,500	114,500 shares
0.220	62,000	62,000 shares
0.230	102,000	102,000 shares
0.235	500	500 shares
0.240	39,000	39,000 shares
0.245	500	500 shares
0.250	20,500